Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts

Documenti analoghi

• Antiretroviral treatment and expression of the mRNA levels for Pgp, MRP1, MRP4 and MRP5 in HIV antiretroviral naïve patients. Follow-up at 48 weeks
  di: Falasca, Francesca, et al.
  Pubblicazione: (2010)
• Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
  di: Erhabor, Osaro, et al.
  Pubblicazione: (2009)
• Changing antiretrovirals whilst viral load <50 copies/ml and relationship with CD4 count changes
  di: Mocroft, A
  Pubblicazione: (2010)
• PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR
  di: Anreddy, Nagaraju, et al.
  Pubblicazione: (2014)
• The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience
  di: Erhabor, Osaro, et al.
  Pubblicazione: (2009)